Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹3,121 Cr₹2,413 Cr₹2,152 Cr₹1,813 Cr₹920 Cr

What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Operating Activities ratio of MANKIND PHARMA is ₹3,121 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹3,121 Cr
Mar2025₹2,413 Cr
Mar2024₹2,152 Cr
Mar2023₹1,813 Cr
Mar2022₹920 Cr

How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹3,121 Cr
29.33
Mar2025 ₹2,413 Cr
12.12
Mar2024 ₹2,152 Cr
18.70
Mar2023 ₹1,813 Cr
97.15
Mar2022 ₹920 Cr -

Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹91,562.1 Cr -3.3% -6.3% -6.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -0.4% -6.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr 0.9% -3.3% 39.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr 0.1% -7.2% 28.2% Stock Analytics
CIPLA ₹108,012.0 Cr -0.3% -4% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr 1.5% 3.1% 0.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-3.3%

-6.3%

-6.7%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses